tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katherine Breedis, 6 are a BUY (100%).
Analyst Katherine Breedis, carries an average stock price target met ratio of 66.67% that have a potential upside of 101.6% achieved within 1497 days. Previously, Katherine Breedis worked at STIFEL.
Katherine Breedis’s has documented 12 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VYGR, Voyager Therapeutics at 28-Jul-2017.
Analyst best performing recommendations are on VYGR (VOYAGER THERAPEUTICS).
The best stock recommendation documented was for VYGR (VOYAGER THERAPEUTICS) at 7/28/2017. The price target of $20 was fulfilled within 63 days with a profit of $10.91 (120.02%) receiving and performance score of 19.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Feb-2025
$166
$36.69 (28.37%)
$175
22 days ago
(08-Jul-2026)
41/43 (95.35%)
$30.18 (22.22%)
557
Hold Since 04-Sep-2024
$120
$-9.31 (-7.20%)
$122
23 days ago
(07-Jul-2026)
75/91 (82.42%)
$-16.36 (-12.00%)
1717
Buy Since 24-Nov-2025
$156
$26.69 (20.64%)
$157
23 days ago
(07-Jul-2026)
3/5 (60%)
$19.64 (14.40%)
25
Hold Since 06-Jul-2026
$155
$25.69 (19.87%)
$69
24 days ago
(06-Jul-2026)
2/3 (66.67%)
$25.39 (19.59%)
46
Buy Since 22-Apr-2025
$155
$25.69 (19.87%)
$155
24 days ago
(06-Jul-2026)
21/25 (84%)
$25.39 (19.59%)
352
What Year was the first public recommendation made by Katherine Breedis?
